IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — HLSQ

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.351.176.9214.0520.1223.5431.6143.0122.4529.7129.3537.0737.7444.7667.3546.2739.41
Short-term Investments0.23------------------2.003.508.0010.00----13.21
Accounts Receivable0.33--------------------------------
Total Current Assets2.423.048.8616.6423.5328.3235.0847.1025.3033.1932.9342.5348.3158.1169.8049.8456.54
Property, Plant & Equipment0.10--3.004.254.706.586.957.444.184.394.585.035.255.465.865.123.53
Goodwill----------0.8015.7915.79------------------
Intangible Assets----------------------0.380.761.141.902.282.66
Total Non-current Assets*25.770.2117.3121.4222.1231.6633.5434.517.768.068.479.3710.0710.6412.0011.8110.53
Total Assets28.193.2526.1738.0545.6559.9868.6281.6133.0641.2541.4151.9058.3868.7481.8061.6567.06
Accounts Payable--------------------1.361.781.661.401.881.772.69
Short-term Debt0.21------------------------------13.21
Total Current Liabilities10.182.455.236.267.028.947.3110.7112.7811.6710.207.486.499.859.007.767.80
Long-term Debt0.25------------5.4012.0713.3514.5815.0015.0015.0014.234.884.74
Total Non-current Liabilities0.381.6910.4612.6314.1313.1433.8948.0212.1213.7215.0617.8619.1518.8819.375.305.31
Total Liabilities*10.564.1315.6818.8921.1622.0841.1991.1524.9025.3925.2625.3425.6428.7328.3713.0613.11
Retained Earnings(239.81)(236.04)(203.56)(194.39)(188.36)(166.18)(175.83)(180.30)(157.48)(149.57)--------------
Total Stockholder Equity10.87(0.88)10.4919.1624.5037.9027.43(9.54)8.1515.8716.1526.5632.7440.0253.4348.5953.95

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.33--------------------------------------
Cost of Revenue0.24--------------------------------------
Gross Profit0.10--------------------------------------
Research & Development----4.916.125.015.256.387.286.904.112.685.643.824.563.203.544.584.936.456.61
Selling, General & Admin5.381.612.292.412.422.513.023.252.832.682.602.152.261.641.992.632.362.482.832.85
Total Operating Expenses5.51--------------------------0.000.130.40------
Operating Income(5.41)(1.30)(17.74)(8.54)(7.43)(7.76)(16.68)(11.33)(9.72)(6.78)(5.27)(7.79)(6.07)(6.21)(5.56)(6.55)(7.32)(7.79)(9.66)(9.83)
Interest Expense--------------0.000.000.850.520.570.750.561.090.980.980.980.980.00
Pretax Income(3.85)(19.14)(13.34)(9.16)(6.03)(7.66)(14.51)9.644.48(17.32)(5.49)(7.90)(6.40)(6.35)(5.85)(6.77)--------
Tax Provision----0.000.000.000.000.000.000.010.010.000.010.010.010.040.010.010.010.050.01
Net Income(3.85)(19.14)(13.34)(9.17)(6.04)(7.66)(14.51)9.644.47(17.33)(5.49)(7.91)(6.41)(6.36)(5.89)(6.78)(7.48)(8.17)(10.46)(10.03)
Basic EPS0.377.38213.800.290.190.3315.10(0.31)(0.01)0.280.600.130.120.202.000.230.250.27----
Diluted EPS0.377.38213.800.290.190.3333.20(0.31)0.070.280.600.130.120.202.000.230.25------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(1.17)(5.41)(4.39)(7.18)(6.11)(8.71)(6.29)(8.10)(11.24)(11.36)(6.24)(5.92)(4.08)(5.04)(7.17)(5.48)(9.09)(7.36)(9.09)(5.68)
Capital Expenditures0.00--0.000.00----0.010.010.01--0.010.030.000.010.030.010.050.020.101.31
Free Cash Flow*(1.17)--(4.39)(7.18)----(6.30)(8.11)(11.25)--(6.25)(5.95)(4.08)(5.05)(7.20)(5.48)(9.14)(7.38)(9.19)(6.99)
Investing Cash Flow(0.56)(1.00)0.00-0.000.060.05-0.00-0.000.050.66(0.01)(0.03)-0.001.991.474.501.95(10.02)(0.10)(1.31)
Financing Cash Flow0.912.621.250.05(0.03)11.91(0.40)0.00(0.20)38.98(1.32)(1.31)4.481.050.000.240.020.043.9828.06

* Derived from reported values